Differentiation of Malignant from Benign Lesions of the Thyroid Gland Using Complementary Scanning with Selenomethionine and Radioiodide
- 1 September 1969
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 170 (3), 396-408
- https://doi.org/10.1097/00000658-196909010-00008
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Role of scintillation scanning in clinical medicine. II.1966
- Se75-selenomethionine incorporation into human plasma proteins and erythrocytesMetabolism, 1966
- The thyroid uptake of selenium-75-selenomethionine: effect of L-thyroxine and thyroid stimulating hormone.1966
- The regional distribution of Se75-selenomethionine in the ratMetabolism, 1966
- Se methionine as a diagnostic agent in malignant lymphoma.1965
- The Thyroid ScintigramRadiology, 1965
- PARATHYROID SCANNING WITH SELENIUM-75 LABELLED METHIONINE.1964
- THE USE OF IODINE 125 IN THYROID SCINTISCANNING.1963
- Scintillation Scanning in the Management of the Clinically Single Thyroid NodulePublished by American Medical Association (AMA) ,1961
- GROSS AND MICROSCOPIC FINDINGS IN CLINICALLY NORMAL THYROID GLANDS*Journal of Clinical Endocrinology & Metabolism, 1955